Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
STEN: Telbivudine Roadmap Strategy in HBeAg-Negative CHB
NCT01521975Phase 4Completed
- Sponsor
- The Third Affiliated Hospital of Sun Yat-sen University
- Start
- Jan 2011
- Primary completion
- Feb 2014
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 4 trial of telbivudine in Chronic Hepatitis B (CHB), sponsored by The Third Affiliated Hospital of Sun Yat-sen University. Started Jan 2011; status: completed.
02
Drugs
telbivudine
03
Conditions
Chronic Hepatitis B (CHB)
Beyond the preview
Go deeper on NCT01521975.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01521975.